ECSP951570A - ANTAGONISTS OF THE MEMBERSHIP REPECTOR - Google Patents

ANTAGONISTS OF THE MEMBERSHIP REPECTOR

Info

Publication number
ECSP951570A
ECSP951570A ECSP951570A ECSP951570A EC SP951570 A ECSP951570 A EC SP951570A EC SP951570 A ECSP951570 A EC SP951570A EC SP951570 A ECSP951570 A EC SP951570A
Authority
EC
Ecuador
Prior art keywords
compounds
repector
membership
antagonists
refers
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Joachim Gante
Horst Juraszyk
Peter Raddatz
Hanns Wurziger
Sabine Bernotat-Danielowski
Guido Melzer
Matthias Wiesner
Claus Fittschen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP951570 priority Critical patent/ECSP951570A/en
Publication of ECSP951570A publication Critical patent/ECSP951570A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se refiere a los compuestos de fórmula I en la que R1, R2 y R3 tienen los significados indicados, y a sus sales aceptables desde el punto de vista fisiológico. También se refiere a un procedimiento para preparar estos compuestos y al empleo de los mismos en calidad de medicamentos. Los compuestos del invento inhiben la unión de fibrinógeno a su receptor correspondiente, y pueden ser empleados para el tratamiento de trombosis, osteoporosis, enfermedades tumorales, apoplejías, infarto del miocardio, isquemias, infecciones, arteriosclerosis y enfermedades osteolíticas.It refers to the compounds of formula I in which R1, R2 and R3 have the indicated meanings, and to their physiologically acceptable salts. It also refers to a process for preparing these compounds and their use as drugs. The compounds of the invention inhibit the binding of fibrinogen to its corresponding receptor, and can be used for the treatment of thrombosis, osteoporosis, tumor diseases, strokes, myocardial infarction, ischemia, infections, arteriosclerosis and osteolytic diseases.

ECSP951570 1995-11-01 1995-11-01 ANTAGONISTS OF THE MEMBERSHIP REPECTOR ECSP951570A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP951570 ECSP951570A (en) 1995-11-01 1995-11-01 ANTAGONISTS OF THE MEMBERSHIP REPECTOR

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP951570 ECSP951570A (en) 1995-11-01 1995-11-01 ANTAGONISTS OF THE MEMBERSHIP REPECTOR

Publications (1)

Publication Number Publication Date
ECSP951570A true ECSP951570A (en) 1997-06-11

Family

ID=42042212

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP951570 ECSP951570A (en) 1995-11-01 1995-11-01 ANTAGONISTS OF THE MEMBERSHIP REPECTOR

Country Status (1)

Country Link
EC (1) ECSP951570A (en)

Similar Documents

Publication Publication Date Title
MX9504630A (en) NEW DERIVATIVES OF OXAZOLIDINONE, ANTAGONIST OF THE ADHESION RECEPTOR, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
AR007160A1 (en) ADHESION RECEPTOR ANTAGONIST COMPOUNDS, PROCEDURE FOR PREPARING THESE COMPOUNDS AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
AR003121A1 (en) ADHESION RECEPTOR ANTAGONISTS, PROCEDURE TO PREPARE THEM, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE TO PREPARE MEDICINES AND FIGHT DISEASES
ES2183332T3 (en) AROMATIC BICYCLE AMINO ACIDS.
ES2193337T3 (en) USE OF STRONTIUM SALTS FOR THE TREATMENT OF ARTROSIS.
AR007640A1 (en) DERIVATIVES OF PHENYLALANINE, PROCEDURE TO PREPARE THEM, PHARMACEUTICAL PREPARATIONS THAT CONTAIN THEM AND USE THEM TO PREPARE A MEDICINAL PRODUCT THAT ACTS AS AN INHIBITOR OF ALPHA INTEGRINE (v)
MX9300842A (en) SULFONAMIDE ENDOTHELINE ANTAGONISTS.
ES2084944T3 (en) THERAPEUTIC AMIDES.
UY26839A1 (en) PRODUCTS BY DERIVATIVES OF LA 4 - FENIL - PIRIDINA
ES2100907T3 (en) BENZIMIDAZOLES, MEDICINES CONTAINING THESE COMPOUNDS AND PROCEDURE FOR THEIR PREPARATION.
ES2088915T3 (en) BENZIMIDAZOLES, MEDICINES CONTAINING THESE COMPOUNDS AND PROCEDURE FOR THEIR PREPARATION.
AR028810A1 (en) DERIVATIVES OF ARILPIPERAZINIL-CICLOHEXIL INDOL, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM AND THE USE OF THE SAME FOR THE MANUFACTURE OF MEDICINES FOR THE TREATMENT OF DEPRESSION
AR029803A1 (en) IMIDAZOLS REPLACED WITH PIRIDILE AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM
ES2169046T3 (en) PROSTAGLANDINE ANALOG FOR THE TREATMENT OF OSTEOPOROSIS.
UY28859A1 (en) SELECTED CGRP ANTAGONISTS, PROCEDURE FOR PREPARATION AS WELL AS ITS USE AS A MEDICINAL PRODUCT
ES2123810T3 (en) HETERO CYCLES USEFUL AS NEUROQUININE ANTAGONISTS.
PA8518701A1 (en) USEFUL THIOPHEN DERIVATIVES AS ANTI-TARGET AGENTS
UY27374A1 (en) USE OF NK-1 RECEIVER ANTAGONISTS FOR THE TREATMENT OF BRAIN, SPINAL OR NEURONAL INJURIES
BG101110A (en) SUBSTITUTED PIRIMIDINE COMPOUNDS AND THEIR USE
GT200000197A (en) 2- (3,5-BIS-TRIFLUOROMETIL-PHENYL) -N-METIL-N- (6- MORFOLIN-4-IL-4-O TOLIL-PIRIDIN-3-IL) -ISOBUTIRAMIDE.
ECSP055704A (en) 4- (INDAZOL-3-IL) SUBSTITUTED PHENOLS AS LEGANDS OF THE STRATEGEN RECEIVER (RE) AND ITS USE IN THE TREATMENT OF INFLAMMATORY DISEASES
MX9306311A (en) ANTAGONIST COMPOUNDS OF THE 5-HT4 RECEPTOR, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
MX9204094A (en) DERIVATIVES OF PHENYLALKYL, MEDICINES CONTAINING THESE COMPOUNDS AND PROCEDURE FOR THEIR PREPARATION.
AR002245A1 (en) ANTAGONISTS OF THE ADHESION RECEPTOR, PROCEDURE TO PREPARE THEM, PHARMACEUTICAL PREPARATIONS THAT CONTAIN THEM AND THE USE OF THE SAME TO PREPARE MEDICINES.
AR026267A1 (en) CYTOTOXIC HETEROCICLIC AGENTS.